MedTrace Logo

Clinical Cohorts for Validation of New Digital Biomarkers

NCT05855538 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-05-11

No results posted yet for this study

Summary

The MAESTRIA study is an international, multi-centre, non-interventional, observational registry. The main goal is to enrol a representative group of European patients diagnosed with Atrial Fibrillation (AF) to analyse clinical and relevant parameters (digitalised ECG, echocardiograms, cardiac CTs, MRIs and blood biomarkers) that could be used during clinical practise for the diagnosis of atrial cardiomyopathy. The AF patients will be distributed in 3 groups according to the different manifestation of AF: paroxysmal, persistent and permanent AF.

Conditions

Sponsors & Collaborators

  • Atrial Fibrillation Network

    lead OTHER

Principal Investigators

  • Stéphan Hatem, Prof · ICAN Nutrition Education and Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-02
Primary Completion
2024-08-31
Completion
2025-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855538 on ClinicalTrials.gov